In previous studies Gal was shown to be an anti-inflammatory compound that inhibits Interleukin-6 (IL6) signaling in a Janus Kinase/Signal Transducer and Activator of Transcription (STAT)—dependent manner and reduces experimental asthma [12, 13]. The gene discussed is IL6; the disease is asthma.